Development of technologies controlling DNA replication for applications in a platform for gene therapy vectors and in the discovery of new therapeutic agents for cancer and tissue regeneration.
Replicor, Inc.
Replicor - Accueil
2024-06-16
Science, Biology, Genetics, Eukaryotic - Replicor, Inc.. Development of technologies controlling DNA replication for applications in a platform for gene therapy vectors and in the discovery of new therapeutic agents for cancer and tissue regeneration.